Assenagon Asset Management’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $164K | Sell |
|
|||||
|
2024
Q2 | $4.24M | Buy |
|
|||||
|
2024
Q1 | $5.07M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $603K | Hold |
|
|||||
|
2022
Q4 | $487K | Sell |
|
|||||
|
2022
Q3 | $895K | Hold |
|
|||||
|
2022
Q2 | $1.13M | Sell |
|
|||||
|
2022
Q1 | $1.3M | Buy |
|
|||||
|
2021
Q4 | $774K | Sell |
|
|||||
|
2021
Q3 | $3.18M | Sell |
|
|||||
|
2021
Q2 | $5.69M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $241K | Sell |
|
|||||
|
2020
Q3 | $2.81M | Sell |
|
|||||
|
2020
Q2 | $6.69M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $317K | Buy |
|